Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With

Anirudh Kumar1, Chetan P Huded1, Leon Zhou1

  • 1Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.

Insights

A new comprehensive ST-elevation myocardial infarction (STEMI) protocol reduced cardiogenic shock (CS) incidence and improved patient outcomes. This STEMI protocol led to better infarct size, ejection fraction, and lower in-hospital mortality for STEMI-associated CS patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Mortality in ST-elevation myocardial infarction (STEMI) patients with cardiogenic shock (CS) is rising.
  • The effectiveness of a comprehensive STEMI protocol (CSP) in improving care and reducing mortality for these patients remains unclear.

Purpose of the Study:

  • To evaluate the impact of a 4-step comprehensive STEMI protocol (CSP) on the incidence and outcomes of STEMI-associated cardiogenic shock (CS).

Main Methods:

  • Implementation of a 4-step CSP: ED catheterization lab activation, STEMI Safe Handoff Checklist, immediate lab transfer, and radial-first PCI.
  • Studied 1,272 STEMI patients undergoing PCI, comparing CS incidence, care delivery, and mortality before and after CSP implementation.

Main Results:

  • CSP implementation significantly reduced CS incidence (13.0% vs 7.8%, p=0.003).
  • CSP patients showed improved door-to-balloon time (95.0 vs 129.0 min, p=0.001) and increased trans-radial PCI use (44.2% vs 9.6%, p<0.001).
  • Significant improvements were observed in infarct size (CK-MB 151.5 vs 220.9 ng/ml, p=0.005), ejection fraction (46.7% vs 40.8%, p=0.037), and in-hospital mortality (14.0% vs 30.9%, p=0.037) in the CSP group.

Conclusions:

  • The comprehensive STEMI protocol (CSP) is associated with reduced CS incidence in STEMI patients.
  • CSP implementation improves key clinical outcomes, including infarct size, ejection fraction, and in-hospital mortality.
  • This protocol offers a promising strategy to enhance care for STEMI patients with associated cardiogenic shock.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
459
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
179
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
94
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
325
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
119